West Pharmaceutical Services (WST) Rebounded in Q3

2 weeks ago 13

Soumya Eswaran

Thu, December 4, 2025 astatine 7:45 AM CST 3 min read

Brown Advisory, an concern absorption company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The strategy returned -0.88% (net) during the 3rd quarter, underperforming the benchmark, the Russell 1000 Growth Index. Even though the portfolio has important vulnerability to AI, its underweight to the astir speculative momentum-driven parts of the commercialized was a headwind to performance. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, Brown Advisory Large-Cap Growth Strategy highlighted stocks specified arsenic West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc. (NYSE:WST) designs, manufactures, and sells containment and transportation systems for injectable drugs and healthcare products. The one-month instrumentality for West Pharmaceutical Services, Inc. (NYSE:WST) was 3.26%, and its shares mislaid 10.65% implicit the past 52 weeks. On December 03, 2025, West Pharmaceutical Services, Inc. (NYSE:WST) banal closed astatine $284.31 per share, with a marketplace capitalization of $18.554 billion.

Brown Advisory Large-Cap Growth Strategy stated the pursuing regarding West Pharmaceutical Services, Inc. (NYSE:WST) successful its 3rd 4th 2025 capitalist letter:

"West Pharmaceutical Services, Inc. (NYSE:WST): Manufactures and markets pharmaceuticals, biologics, vaccines & user healthcare products. West Pharmaceutical Services (WST), a aesculapian supplies institution specializing successful elastomer-based solutions, continued to rebound from its volatile commencement to 2025. On the heels of a beardown net study that exceeded statement expectations and the hiring of a caller CFO, the banal moved 20% higher during the quarter. The institution has delivered consecutive quarters of gross maturation successful its high-value merchandise segment, portion inventory destocking headwinds proceed to ease."

TD Cowen Initiates Coverage connected West Pharmaceutical (WST) with Buy Rating and $350 Target

West Pharmaceutical Services, Inc. (NYSE:WST) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 49 hedge money portfolios held West Pharmaceutical Services, Inc. (NYSE:WST) astatine the extremity of the 3rd quarter, which was 46 successful the erstwhile quarter. In Q3 2025, West Pharmaceutical Services, Inc. (NYSE:WST) reported revenues of $805 million, marking an summation of 5% connected an integrated basis. While we admit the imaginable of West Pharmaceutical Services, Inc. (NYSE:WST) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.